|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/12 | |
| C07K 1/14 | |||
| A61K 48/00 | |||
| C12N 15/00 | |||
| A61K 31/64 | |||
| A61K 31/451 | |||
| A61K 31/4453 | |||
| A61K 31/00 | |||
| A61K 45/06 | |||
| A61K 31/195 | |||
| A61K 31/454 | |||
| A61K 31/198 |
| (11) | Number of the document | 2167107 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08771576.9 |
| Date of filing the European patent application | 2008-06-20 | |
| (97) | Date of publication of the European application | 2010-03-31 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/067640 |
| Date | 2008-06-20 |
| (87) | Number | WO 2009/002832 |
| Date | 2008-12-31 |
| (30) | Number | Date | Country code |
| 945636 P | 2007-06-22 | US | |
| 945811 P | 2007-06-22 | US | |
| 945825 P | 2007-06-22 | US |
| (72) |
SIMARD, Marc, J., US
|
| (73) |
The United States of America, as represented by the Department of Veterans Affairs,
Office of General Counsel - PSG IV (024) 810 Vermont Ave. N. W., Washington, D.C. 20420,
US
University of Maryland, Baltimore, a constituent Institution of the University System of Maryland an Agency of the State of Maryland 620 W. Lexington Street, 4th floor, Baltimore, Maryland 21201-1691, US |
| (54) | INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY |
| INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY |